[EXPLORATION OF THE ACTH HYPOPHYSEAL RESERVE WITH METOPIRONE IN DIFFERENT ENDOCRINOPATHIES].
D015068:17-Ketosteroids; D000172:Acromegaly; D000308:Adrenocortical Hyperfunction; D000324:Adrenocorticotropic Hormone; D019411:Clinical Laboratory Techniques; D003480:Cushing Syndrome; D003560:Cysts; D005260:Female; D006801:Humans; D007006:Hypogonadism; D007018:Hypopituitarism; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D009369:Neoplasms / Q000532:radiotherapy*; D010053:Ovary; D010600:Pharmacology; D010902:Pituitary Gland; D010911:Pituitary Neoplasms; D011867:Radioisotope Teletherapy; D012595:Scleroderma, Systemic; D050035:Sexual Infantilism; D014116:Toxicology; D014556:Urine
D015068:17-Ketosteroids; D000451:Mineralocorticoid Receptor Antagonists; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone
17-KETOSTEROIDS; ACROMEGALY; ADRENAL GLAND HYPERFUNCTION; ALDOSTERONE ANTAGONISTS; CORTICOTROPIN; CUSHING'S SYNDROME; CYSTS; DIAGNOSIS, LABORATORY; HYPOPITUITARISM; INFANTILISM; METYRAPONE; NEOPLASM RADIOTHERAPY; OVARY; PHARMACOLOGY; PITUITARY NEOPLASMS; RADIOISOTOPE TELETHERAPY; SCLERODERMA; TOXICOLOGIC REPORT; URINE
EXPLORACI'ON DE LA RESERVA HIPOFISARIA DE ACTH CON METOPIRONA EN DIVERSAS ENDOCRINOPAT'IAS.